RISPRIT Trademark

Trademark Overview

On Wednesday, March 3, 2010, a trademark application was filed for RISPRIT with the United States Patent and Trademark Office. The USPTO has given the RISPRIT trademark a serial number of 77949627. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 16, 2013. This trademark is owned by Glaxo Group Limited. The RISPRIT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
risprit

General Information

Serial Number77949627
Word MarkRISPRIT
Filing DateWednesday, March 3, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 16, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 22, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 9, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN
GB

Trademark Events

Event DateEvent Description
Monday, September 16, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 16, 2013ABANDONMENT - NO USE STATEMENT FILED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 17, 2013EXTENSION 5 GRANTED
Monday, January 7, 2013EXTENSION 5 FILED
Monday, January 7, 2013TEAS EXTENSION RECEIVED
Saturday, July 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 20, 2012EXTENSION 4 GRANTED
Tuesday, July 17, 2012EXTENSION 4 FILED
Tuesday, July 17, 2012TEAS EXTENSION RECEIVED
Wednesday, January 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 17, 2012EXTENSION 3 GRANTED
Wednesday, January 11, 2012EXTENSION 3 FILED
Wednesday, January 11, 2012TEAS EXTENSION RECEIVED
Tuesday, August 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2011EXTENSION 2 GRANTED
Monday, July 18, 2011EXTENSION 2 FILED
Monday, August 8, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 18, 2011TEAS EXTENSION RECEIVED
Saturday, January 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 13, 2011EXTENSION 1 GRANTED
Thursday, January 13, 2011EXTENSION 1 FILED
Thursday, January 13, 2011TEAS EXTENSION RECEIVED
Tuesday, August 17, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 21, 2010ASSIGNED TO EXAMINER
Tuesday, June 22, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 22, 2010PUBLISHED FOR OPPOSITION
Wednesday, May 19, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 19, 2010ASSIGNED TO LIE
Wednesday, May 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 10, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 6, 2010ASSIGNED TO EXAMINER
Tuesday, March 9, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 6, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

risprit pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic